The Impact of Restrictive Abortion Laws on Medical Residency Applications and Healthcare Access: Implications for Maternal Health Equity
Journal of Pregnancy · 2026-01 · 2026 (1)
DOI: 10.1155/jp/6613889 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pregnancy, online erschienen am 30.06.2026. Verfasst von Brooke Gully und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education, Anne Burnett Marion School of Medicine at TCU, Fort Worth, Texas, USA. Hauptthemen laut MEDLINE: Internship and Residency, Health Services Accessibility, Maternal Health, Health Equity. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The 2022 Supreme Court ruling in Dobbs v. Jackson Women′s Health Organization returned regulatory authority over abortion to the states and precipitated a wave of restrictive state‐level legislation. This narrative review examines how these state responses have influenced medical residency applications, physician training, and maternal health equity. Existing research indicates that restrictive state laws have contributed to a decline in residency applications to programs in jurisdictions with near‐total abortion bans. A growing body of evidence suggests that many medical students, particularly those seeking OBGYN training, prioritize programs in states with fewer restrictions to ensure comprehensive clinical education. These trends may exacerbate existing maternity care deserts by contributing to physician shortages, particularly in underserved and rural areas. The review further explores how the post‐ Dobbs regulatory environment impacts physician training. Many OBGYN residency programs in restrictive states struggle to provide abortion training, often requiring residents to travel out of state, which creates significant financial and logistical burdens. Additionally, a lack of transparency regarding training availability in these states complicates the ability of prospective residents to assess program offerings. Beyond residency applications, these state‐level restrictions have affected practicing physicians, contributing to burnout, legal uncertainties, and ethical dilemmas. Many providers in restrictive jurisdictions report moral distress and legal risks when making clinical decisions, leading some to relocate to states with greater reproductive freedoms. The compounded effects of these laws may widen healthcare disparities, disproportionately affecting marginalized communities, particularly low‐income individuals and people of color. Given the limited longitudinal evidence since Dobbs , continued monitoring of OBGYN residency applications, training availability, workforce distribution, and maternal health outcomes is needed to determine the persistence and magnitude of these effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Education, Anne Burnett Marion School of Medicine at TCU, Fort Worth, Texas, USA.
- Department of Obstetrics and Gynecology, Anne Burnett Marion School of Medicine at TCU, Fort Worth, Texas, USA.
ORCID-Profile: Brooke Gully, Ellie Whitney, Paige Johnson, Shanna Combs
Zitieren
APA
Gully, B., Whitney, E., Johnson, P., & Combs, S. (2026). The Impact of Restrictive Abortion Laws on Medical Residency Applications and Healthcare Access: Implications for Maternal Health Equity. Journal of Pregnancy, 2026(1). https://doi.org/10.1155/jp/6613889
Vancouver
Gully B, Whitney E, Johnson P, Combs S. The Impact of Restrictive Abortion Laws on Medical Residency Applications and Healthcare Access: Implications for Maternal Health Equity. Journal of Pregnancy. 2026;2026(1). doi:10.1155/jp/6613889
BibTeX
@article{Gully2026,
author = {Gully, Brooke and Whitney, Ellie and Johnson, Paige and Combs, Shanna},
title = {The Impact of Restrictive Abortion Laws on Medical Residency Applications and Healthcare Access: Implications for Maternal Health Equity},
journal = {Journal of Pregnancy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jp/6613889}
}
EUVIMED